DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 52-Week Low - Should You Sell?

Key Points

• DENTSPLY SIRONA shares hit a new 52-week low, trading as low as $8.38, well below their 50-day and 200-day moving averages.
• Analyst sentiment is mixed but leans cautious: the stock has an average rating of “Hold” and an average price target of $13.31, with three Buy, eight Hold and three Sell ratings.
• The company exceeded quarterly EPS and revenue estimates, but revenue declined 4.1% year over year and the business reported a negative net margin; institutional investors nonetheless own approximately 95.7% of the shares.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s stock price hit a new 52-week low during trading on Wednesday. The stock traded as low as $8.38 and last traded at $8.4420, with a volume of 186155 shares changing hands. The stock had previously closed at $8.52.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. Barrington Research set a $15.00 price target on DENTSPLY SIRONA in a report on Monday, August 10th. Piper Sandler lifted their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 29th. BMO Capital Markets lowered their target price on shares of DENTSPLY SIRONA from $13.00 to $10.00 and set a "market perform" rating for the company in a research note on Thursday, September 17th. Barclays raised their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an "underweight" rating in a research note on Monday, August 24th. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of DENTSPLY SIRONA in a report on Monday, August 3rd. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $13.31.

DENTSPLY SIRONA Stock Down 0.6%

The business's 50-day simple moving average is $10.91 and its 200 day simple moving average is $11.19. The firm has a market cap of $1.69 billion, a PE ratio of -3.08, a P/E/G ratio of 1.09 and a beta of 0.87. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.17. The firm had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The company's quarterly revenue was down 4.1% on a year-over-year basis. During the same period last year, the firm earned $0.52 earnings per share. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. acquired a new position in DENTSPLY SIRONA during the 2nd quarter valued at about $283,405,000. Southpoint Capital Advisors LP purchased a new stake in shares of DENTSPLY SIRONA during the first quarter worth about $116,000,000. Armistice Capital LLC raised its position in shares of DENTSPLY SIRONA by 27.2% in the 4th quarter. Armistice Capital LLC now owns 7,298,000 shares of the medical instruments supplier's stock valued at $83,416,000 after purchasing an additional 1,562,000 shares during the last quarter. Invenomic Capital Management LP raised its position in shares of DENTSPLY SIRONA by 17.9% in the 4th quarter. Invenomic Capital Management LP now owns 5,132,036 shares of the medical instruments supplier's stock valued at $58,659,000 after purchasing an additional 780,837 shares during the last quarter. Finally, Edmond DE Rothschild Holding S.A. acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $47,780,000. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

Dentsply Sirona is a global dental products and technologies company that develops, manufactures and markets solutions for dental professionals, laboratories and patients. Its portfolio includes consumable products, dental equipment and digital technologies used in preventive, restorative, endodontic, orthodontic, implant and prosthetic dentistry.

The company offers dental treatment centers, imaging systems, CAD/CAM systems, intraoral scanners, milling and 3D-printing solutions, instruments, endodontic files and equipment, restorative materials, dental implants, prosthetic components and orthodontic products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.